Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 4;19(5):1228-1235.
doi: 10.5114/aoms/163368. eCollection 2023.

Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial

Federica Fogacci  1   2 , Marina Giovannini  1   2 , Edigio Imbalzano  3 , Elisa Grandi  1 , Elisabetta Rizzoli  1 , Sergio D'Addato  1 , Arrigo F G Cicero  1   2
Affiliations

Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial

Federica Fogacci et al. Arch Med Sci. .

Abstract

Introduction: In addition to healthy lifestyle and balanced diet, nutraceutical supplementation may be useful to maintain overall metabolic wellness. The aim of the present study was to assess the metabolic and vascular effects of a new, highly standardized bergamot phytocomplex supplement in healthy volunteers with the features of metabolic syndrome.

Material and methods: We carried out a double-blind, randomized, placebo-controlled, three-arm, parallel-group clinical trial in 90 adult subjects (30 per group) treated for 12 weeks with two different dosages of a highly standardized bergamot phytocomplex (Endoberg by AKHYNEX and Kalita by Giellepi) or placebo. Lipid plasma levels, glycemia, plasma hs-CRP, HOMA-IR, body fat, endothelial reactivity and fatty liver index were assessed at baseline, after 6 weeks and at the end of treatment in all subjects.

Results: At the end of treatment, both tested bergamot extract doses were able to significantly improve atherogenic dyslipidemia and insulin sensitivity (p < 0.05) compared to placebo. In the high-dose treated group, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), non high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) improved versus placebo (p < 0.05) just after 6 weeks of treatment. After 12 weeks of treatment, TC decreased by 13.2 ±2.1%, LDL-C by 17.7 ±3.2%, non-HDL-C by 17.5 ±3.1%, TG by 16.6 ±3.3%, TG/HDL-C by 22.5 ±4.4%, homeostasis insulin resistance index (HOMA-IR) by 12.2 ±2.1%, γ-glutamyl transferase (GGT) by 22.2 ±4.6%, and high-sensitivity C-reactive protein (hs-CRP) by 17.9 ±3.4% versus baseline (p < 0.05) and vs. placebo (p < 0.05). Percentage body fat and endothelial reactivity improved versus baseline, but not versus placebo, in the high-dose treatment only (p < 0.05).

Conclusions: The tested bergamot phytocomplex was able to significantly improve glucose and lipid metabolism, as well as inflammation, and might represent a novel multi-target approach to control metabolic syndrome.

Keywords: Creactive protein; TG/HDL index; bergamot; metabolic syndrome; randomized clinical trial.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Trial selection and design according the study protocol
See this image and copyright information in PMC

References

    1. Scuteri A, Laurent S, Cucca F, et al. .; Metabolic Syndrome and Arteries Research (MARE) Consortium . Metabolic syndrome across Europe: different clusters of risk factors. Eur J Prev Cardiol 2015; 22: 486-91. - PMC - PubMed
    1. Park S, Lee S, Kim Y, et al. . Altered risk for cardiovascular events with changes in the metabolic syndrome status: a nationwide population-based study of approximately 10 million persons. Ann Intern Med 2019; 171: 875-84. - PubMed
    1. Dayi T, Ozgoren M. Effects of the Mediterranean diet on the components of metabolic syndrome. J Prev Med Hyg 2022; 63(2 Suppl 3): E56-64. - PMC - PubMed
    1. Kwon DH, Cho YG, Park HA, Koo HS. The difference in the prevalence of metabolic syndrome according to meeting guidelines for aerobic physical activity and muscle-strengthening exercise: a cross-sectional study performed using the Korea National Health and Nutrition Examination Survey, 2014-2019. Nutrients 2022; 14: 5391. - PMC - PubMed
    1. Mazidi M, Katsiki N, Banach M. A greater flavonoid intake is associated with lower total and cause-specific mortality: a meta-analysis of cohort studies. Nutrients 2020; 12: 2350. - PMC - PubMed